Home 
Today's Top Picks 
Top Performers 
Watchlist 
My Robo Portfolios 
ETF Zone 
Help & Tutorial 
Cancel anytime
- Chart
- Upturn Summary
- Highlights
- Valuation
Upturn AI SWOT - About
American Oncology Network Inc (AONCW)
- BUY Advisory
- SELL Advisory (Profit)
- SELL Advisory (Loss)
- Profit
- Loss
- Pass (Skip investing)
Stock price based on last close (see disclosures)
- ALL
- YEAR
- MONTH
- WEEK
Upturn Advisory Summary
07/03/2025: AONCW (2-star) has a low Upturn Star Rating. Not recommended to BUY.
Upturn Star Rating
Below Average Performance
These Stocks/ETFs, based on Upturn Advisory, often underperform the market, warranting careful consideration before investing.
Number of Analysts
0 Analysts rated it
Very few follow this stock; limited insights, higher-risk early investing.
Analysis of Past Performance
Type Stock | Historic Profit 238.12% | Avg. Invested days 21 | Today’s Advisory Consider higher Upturn Star rating |
Upturn Star Rating | Upturn Advisory Performance  2.0 | Stock Returns Performance  5.0 |
| Profits based on simulation | Last Close 07/03/2025 |
Key Highlights
Company Size ETF | Market Capitalization 0 USD | Price to earnings Ratio - | 1Y Target Price - |
Price to earnings Ratio - | 1Y Target Price - | ||
Volume (30-day avg) - | Beta 0.61 | 52 Weeks Range 0.04 - 1.83 | Updated Date 06/8/2025 |
52 Weeks Range 0.04 - 1.83 | Updated Date 06/8/2025 | ||
Dividends yield (FY) - | Basic EPS (TTM) - |
Earnings Date
Report Date - | When - | Estimate - | Actual - |
Profitability
Profit Margin -0.23% | Operating Margin (TTM) 1.7% |
Management Effectiveness
Return on Assets (TTM) -2.38% | Return on Equity (TTM) -30.17% |
Valuation
Trailing PE - | Forward PE - | Enterprise Value - | Price to Sales(TTM) - |
Enterprise Value - | Price to Sales(TTM) - | ||
Enterprise Value to Revenue - | Enterprise Value to EBITDA - | Shares Outstanding - | Shares Floating 8989380 |
Shares Outstanding - | Shares Floating 8989380 | ||
Percent Insiders - | Percent Institutions - |
Upturn AI SWOT
American Oncology Network Inc
Company Overview
History and Background
American Oncology Network (AON) was founded in 2018. AON aims to support independent community oncology practices by providing resources and expertise to enhance patient care. The company has rapidly grown through partnerships with community-based oncology practices across the US.
Core Business Areas
- Physician Partnership: AON partners with independent oncology practices, providing them with access to a comprehensive suite of resources and support services.
- Group Purchasing Organization: AON leverages its scale to negotiate favorable pricing on pharmaceuticals and medical supplies through its GPO.
- Technology and Infrastructure: AON provides advanced technology solutions, including electronic health records (EHR) and data analytics, to enhance clinical decision-making and operational efficiency.
- Clinical Trial Access: AON expands clinical trial access for patients in community settings, promoting innovation and improving outcomes.
Leadership and Structure
AON has a leadership team comprised of experienced healthcare executives and oncology professionals. The organizational structure is designed to support and empower its partner practices.
Top Products and Market Share
Key Offerings
- Practice Management Services: AON provides comprehensive practice management services to its partner practices, including billing, coding, and revenue cycle management. Market share data specific to AON's practice management services is not publicly available. Competitors include McKesson, Cardinal Health, and AmerisourceBergen.
- Revenue: Data not publicly available.
- Group Purchasing Organization (GPO): AON's GPO leverages collective bargaining power to secure competitive pricing on pharmaceuticals and medical supplies. GPO market share data is complex and not easily attributed to a single company. Competitors include Vizient, Premier, and HealthTrust Purchasing Group.
- Revenue: Data not publicly available.
- Revenue: Data not publicly available.
- Technology Platform: AON offers a technology platform that integrates EHR, data analytics, and other tools to support clinical decision-making. Data not publicly available. Competitors are Flatiron Health (Roche), McKesson and Cardinal Health
Market Dynamics
Industry Overview
The oncology market is characterized by increasing incidence rates, advancements in treatment options, and a growing emphasis on personalized medicine. Community oncology practices play a vital role in delivering cancer care to patients in local settings.
Positioning
AON is positioned as a strategic partner to independent oncology practices, enabling them to thrive in a challenging healthcare environment through the provision of resources, technology, and expertise.
Total Addressable Market (TAM)
The total addressable market for oncology care in the US is estimated to be hundreds of billions of dollars. AON is positioned to capture a significant share of this market by supporting and expanding its network of community oncology practices.
Upturn SWOT Analysis
Strengths
- Strong network of partner practices
- Comprehensive suite of services
- Experienced leadership team
- Focus on community oncology
Weaknesses
- Dependence on partner practice performance
- Integration challenges with diverse practices
- Limited brand recognition compared to larger players
Opportunities
- Expansion into new geographic markets
- Development of innovative treatment protocols
- Strategic partnerships with pharmaceutical companies
- Increased adoption of value-based care models
Threats
- Consolidation in the healthcare industry
- Changes in reimbursement policies
- Increased competition from larger oncology networks
- Rising drug costs
Competitors and Market Share
Key Competitors
- US Oncology Network (McKesson), Cardinal Health Specialty Solutions, OneOncology
Competitive Landscape
AON differentiates itself through its focus on empowering community oncology practices with comprehensive resources and technology, while larger networks may offer greater scale and established infrastructure. OneOncology focuses on similar physician partnership model.
Growth Trajectory and Initiatives
Historical Growth: Historical growth is not publicly disclosed due to AON being a private company.
Future Projections: Future projections are unavailable as AON is privately held, and analyst estimates are not published.
Recent Initiatives: Recent initiatives include expanding the network of partner practices, investing in technology solutions, and developing clinical pathways to improve patient outcomes.
Summary
American Oncology Network is a growing company focused on supporting community oncology practices. Its strength lies in its partnership model and comprehensive service offerings. Challenges include integrating diverse practices and competing with larger, more established players. Future growth will depend on expanding its network and demonstrating value to its partner practices.
Peer Comparison
Sources and Disclaimers
Data Sources:
- Company Website
- Industry Reports
- Press Releases
- Publicly available information
Disclaimers:
Financial data and market share information are estimates based on available data and industry reports. The analysis is for informational purposes only and should not be considered investment advice.
AI Summarization is directionally correct and might not be accurate.
Summarized information shown could be a few years old and not current.
Fundamental Rating based on AI could be based on old data.
AI-generated summaries may have inaccuracies (hallucinations). Please verify the information before taking action.
About American Oncology Network Inc
Exchange NASDAQ | Headquaters Fort Myers, FL, United States | ||
IPO Launch date 2021-05-13 | CEO & Director Mr. Todd Schonherz | ||
Sector Healthcare | Industry Medical Care Facilities | Full time employees 1914 | Website https://www.aoncology.com |
Full time employees 1914 | Website https://www.aoncology.com | ||
American Oncology Network, Inc., through its subsidiaries, provides oncology management services in the United States. The company provides various services to patients, including laboratory services for routine and specialized testing; in-house professional and technical pathology services with pathology reports; in-house specialty pharmacy services with patient education, financial assistance, and 24/7 patient assistance; and care management support services, including nutrition guidance. The company was incorporated in 2017 and is based in Fort Myers, Florida.
Note: This website is maintained by Upturn Corporation, which is an investment adviser registered with the U.S. Securities and Exchange Commission. Such registration does not imply a certain level of skill or training. Investing in securities has risks. Past performance is no guarantee of future returns. No assurance is provided as to any particular investment return, and you may lose money using our services. You are strongly advised to consult appropriate counsel before making any investments in companies you learn about through our services. You should obtain appropriate legal, tax, investment, accounting, and other advice that takes into account your investment portfolio and overall financial situation. You are solely responsible for conducting due diligence on a potential investment. We do not affect trades for you. You will select your own broker through which to transact. Investments are not FDIC insured, they are not guaranteed, and they may lose value. Please see the Privacy Policy, Terms of Use, and Disclosure for more information.